Microbial identification Market Overview
The global microbial identification market size is projected to cross $1.4 billion by 2022, growing at a CAGR of 6.0% during the forecast period. The increasing incidence of infectious diseases, increasing healthcare spending, increasing food safety concerns and technological advancement in microbial identification market are driving the growth of the global microbial identification industry.
GLOBAL MICROBIAL IDENTIFICATION MARKET BY PRODUCT $M (2012–2022)
The microbial identification market in terms of product is segmented into consumables, instruments & software and services. The consumables segment accounted for largest share in the global market, and it is expected to retain its position by 2022 with 47.8% share in the market. The instruments & software segment is predicted to witness the fastest growth during the forecast period.
Based on the method of microbial identification, the global market is segmented into phenotypic and genotypic method. The phenotypic microbial identification segment accounted for largest share in the global microbial identification market, and it is expected to retain its position by 2022 with 63.1% share in the market. The genotypic segment is predicted to witness the fastest growth during the forecast period.
Geographically, the Asia-Pacific microbial identification market is expected to grow at the fastest rate, as compared to other regions owing to growing demand of microbial identifications in Asian countries, such as India and China. In addition, the growing demand for microbial identification products and services in research institutes, pharma and biotech companies, food, water and beverage manufacturers, government environmental agencies and blood banks further drives the market growth. Among the nations in the Asia-Pacific region, the Japanese microbial identification market is the largest and it is expected to grow at a CAGR of 7.0% during the forecast period.
Microbial identification Market Dynamics
The shift from the conventional phenotypic to genotypic identification techniques is a major trend witnessed in the microbial identification market. Genotypic identification is emerging as an alternative to phenotypic method for microbial identification. Genotypic microbial identification methods are less dependent on the culture method, more reliable and are based on nucleic acid analyses.
The advancements in technology have made detection and microbial identification more specific, faster, sensitive and convenient, than traditional assays. Genotypic microbial identification provides technological advancement in the field of microbial identification. The new methods are rapid, provide high throughput time, and are cost effective. MALDI-TOF method is the widely accepted method due to its rapid results, and low consumable cost. It is compatible with large range of culture media and culture conditions. The test only requires a single colony and minimal consumables are required. Thus, the technological advancements in microbial identification is bolstering the growth of the microbial identification market.
Automated microbial identification comprises of automated identification and susceptibility tests, automated incubator readers and automated Southern Blot apparatus. These devices are costly and require trained professionals. In addition, molecular methods, such as microarray analysis, real-time PCR, and gene sequencing are the rapid methods for microbial identification; however, they are very expensive and require highly-trained technicians. For instance, 16S rRNA gene sequencing is used in limited regions due to high cost and requirement for trained professionals for expertise in interpretation. Thus, the high cost would hinder the growth of the global microbial identification market.
Microbial identification Market Competitive Landscape
The key companies operating in the global microbial identification market include Danaher Corporation, Becton, Dickinson and Company, Siemens AG, Shimadzu Corporation, BioMerieux SA, Thermo Fisher Scientific Inc., Qiagen N.V., Midi Inc, Charles River Laboratories Inc., Biolog Inc. and Bruker Corporation.